Ovid Therapeutics (OVID) Short Interest Ratio & Short Volume $0.62 +0.05 (+8.91%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.62 +0.01 (+1.21%) As of 02/21/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ovid Therapeutics Short Interest DataOvid Therapeutics (OVID) has a short interest of 883,700 shares, representing 1.59% of the float (the number of shares available for trading by the public). This marks a 25.26% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.4, indicating that it would take 2.4 days of the average trading volume of 441,937 shares to cover all short positions.Current Short Interest883,700 sharesPrevious Short Interest705,500 sharesChange Vs. Previous Month+25.26%Dollar Volume Sold Short$586,246.58Short Interest Ratio2.4 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares71,010,000 sharesFloat Size55,620,000 sharesShort Percent of Float1.59%Today's Trading Volume577,971 sharesAverage Trading Volume441,937 sharesToday's Volume Vs. Average131% Short Selling Ovid Therapeutics? Sign up to receive the latest short interest report for Ovid Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOVID Short Interest Over TimeOVID Days to Cover Over TimeOVID Percentage of Float Shorted Over Time Ovid Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025883,700 shares $586,246.58 +25.3%1.6%2.4 $0.66 1/15/2025705,500 shares $537,449.90 +2.0%1.3%2.4 $0.76 12/31/2024692,000 shares $646,120.40 -27.0%1.2%2.7 $0.93 12/15/2024947,800 shares $976,234.00 +28.0%1.7%4.5 $1.03 11/30/2024740,300 shares $843,942.00 -2.1%1.3%4.2 $1.14 11/15/2024756,500 shares $801,890.00 +11.3%1.4%4.4 $1.06 10/31/2024679,900 shares $768,287.00 +12.0%1.2%3.8 $1.13 10/15/2024606,900 shares $697,935.00 -4.3%1.0%3.4 $1.15 9/30/2024633,900 shares $748,002.00 -3.1%1.1%2.8 $1.18 9/15/2024653,900 shares $778,141.00 -9.3%1.1%1.4 $1.19 Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024721,300 shares $815,069.00 -10.2%1.2%0.8 $1.13 8/15/2024803,200 shares $907,616.00 -24.9%1.4%0.9 $1.13 7/31/20241,070,000 shares $1.11 million -2.7%1.9%1.2 $1.04 7/15/20241,100,000 shares $1.03 million +6.8%1.9%1.3 $0.94 6/30/20241,030,000 shares $792,276.00 -64.0%1.8%1.2 $0.77 6/15/20242,860,000 shares $9.41 million -0.4%5.0%4.1 $3.29 5/31/20242,870,000 shares $8.78 million +0.7%5.0%15.2 $3.06 5/15/20242,850,000 shares $9.46 million +1.1%5.0%14.6 $3.32 4/30/20242,820,000 shares $8.60 million +0.7%4.8%13.7 $3.05 4/15/20242,800,000 shares $8.96 million No Change4.8%13.4 $3.20 3/31/20242,800,000 shares $8.54 million -23.7%4.8%13.7 $3.05 3/15/20243,670,000 shares $9.98 million +0.6%6.3%17.4 $2.72 2/29/20243,650,000 shares $12.41 million +1.4%6.2%22.9 $3.40 2/15/20243,600,000 shares $13.10 million +7.8%6.1%23.9 $3.64 1/31/20243,340,000 shares $12.93 million +8.4%5.6%23.5 $3.87 1/15/20243,080,000 shares $9.64 million +6.2%5.2%21.9 $3.13 12/31/20232,900,000 shares $9.34 million +16.9%4.9%21.3 $3.22 12/15/20232,480,000 shares $8.53 million +7.8%4.2%18.2 $3.44 11/30/20232,300,000 shares $6.84 million +7.5%3.9%19.2 $2.98 11/15/20232,140,000 shares $7.19 million +6.5%3.7%18 $3.36 10/31/20232,010,000 shares $7.14 million +2.6%3.5%13.2 $3.55 10/15/20231,960,000 shares $7.19 million -5.3%3.4%12.3 $3.67 9/30/20232,070,000 shares $7.95 million +2.0%3.6%13.4 $3.84 9/15/20232,030,000 shares $8.06 million -2.4%3.5%11.9 $3.97 8/31/20232,080,000 shares $7.00 million +12.4%3.6%6.6 $3.37 8/15/20231,850,000 shares $6.64 million +1.1%3.2%5.9 $3.59 7/31/20231,830,000 shares $6.57 million -0.5%3.1%6.3 $3.59 7/15/20231,840,000 shares $6.24 million No Change3.3%6.4 $3.39 6/30/20231,840,000 shares $6.04 million +216.7%3.3%6.4 $3.28 6/15/2023581,000 shares $2.08 million +40.2%1.0%2.2 $3.58How to trade Executive Order 14154 (Ad)Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orders. Among this blizzard of directives – ranging from slapping 25% tariffs on steel to banning the forced use of paper straws… Everyone seems to have missed the most important detail of all. Get the true, untold story of what’s hidden inside Executive Order 14154, here. 5/31/2023414,500 shares $1.47 million +28.7%0.7%3.3 $3.54 5/15/2023322,100 shares $1.12 million +62.3%0.6%3.2 $3.49 4/30/2023198,500 shares $710,630.00 -7.2%0.4%2.2 $3.58 4/15/2023213,900 shares $663,090.00 +2.6%0.4%2.9 $3.10 3/31/2023208,500 shares $537,930.00 -9.8%0.4%3 $2.58 3/15/2023231,200 shares $483,208.00 -5.5%0.4%3.3 $2.09 2/28/2023244,600 shares $604,162.00 +9.1%0.4%2.7 $2.47 2/15/2023224,300 shares $567,479.00 -1.1%0.4%2.6 $2.53 1/31/2023226,700 shares $566,750.00 +3.1%0.4%2.6 $2.50 1/15/2023219,800 shares $523,124.00 +2.9%0.4%2.5 $2.38 12/30/2022213,600 shares $397,296.00 -24.7%0.4%1.8 $1.86 12/15/2022283,500 shares $510,300.00 +4.5%0.5%2.4 $1.80 11/30/2022271,200 shares $480,024.00 -5.8%0.5%2.6 $1.77 11/15/2022287,800 shares $483,504.00 +3.6%0.5%2.8 $1.68 10/31/2022277,700 shares $452,651.00 -3.7%0.5%2.6 $1.63 10/15/2022288,300 shares $449,748.00 +1.8%0.5%2.6 $1.56 9/30/2022283,100 shares $520,904.00 +1.9%0.5%3.1 $1.84 9/15/2022277,800 shares $608,382.00 -3.5%0.5%2.7 $2.19 8/31/2022287,800 shares $578,478.00 +2.5%0.5%2.1 $2.01 8/15/2022280,800 shares $634,608.00 -6.8%0.5%1.6 $2.26 7/31/2022301,200 shares $617,460.00 -11.7%0.5%1.7 $2.05 7/15/2022341,100 shares $689,022.00 -6.9%0.7%1.9 $2.02 6/30/2022366,400 shares $787,760.00 -9.4%0.7%2 $2.15 6/15/2022404,500 shares $728,100.00 -31.7%0.8%2.1 $1.80 5/31/2022592,200 shares $1.00 million -5.5%1.1%3.3 $1.69 5/15/2022626,400 shares $1.37 million -6.9%1.2%3.9 $2.19 4/30/2022672,700 shares $1.85 million -5.6%1.3%4.4 $2.75 4/15/2022712,800 shares $2.29 million -3.0%1.4%3.9 $3.21 3/31/2022735,000 shares $2.31 million +0.3%1.4%3.7 $3.14 3/15/2022733,000 shares $2.29 million +5.3%1.4%3.7 $3.13 2/28/2022696,000 shares $2.36 million +7.2%1.4%3.2 $3.39 2/15/2022649,000 shares $2.08 million -9.2%1.3%3 $3.21 1/31/2022715,000 shares $1.97 million -0.5%1.4%3.1 $2.76 1/15/2022718,800 shares $2.25 million -3.9%1.5%3.3 $3.13 12/31/2021748,200 shares $2.40 million +4.1%1.5%3.6 $3.21 12/15/2021718,600 shares $2.31 million -4.1%1.5%3.1 $3.21 11/30/2021749,200 shares $2.51 million +13.0%1.5%3.4 $3.35 11/15/2021663,000 shares $2.41 million -39.2%1.3%2.7 $3.64 10/29/20211,090,000 shares $3.71 million -4.4%2.2%4.1 $3.40 10/15/20211,140,000 shares $4.10 million +10.7%2.3%4.1 $3.60 9/30/20211,030,000 shares $3.46 million -13.5%2.1%3.4 $3.36 9/15/20211,190,000 shares $4.12 million -26.5%2.5%2.7 $3.46 8/31/20211,620,000 shares $5.72 million -4.1%3.5%3.1 $3.53 8/13/20211,690,000 shares $6.83 million +3.7%3.6%2.8 $4.04 7/30/20211,630,000 shares $6.08 million -1.2%3.5%2.4 $3.73 7/15/20211,650,000 shares $6.09 million -1.2%3.5%2.2 $3.69 6/30/20211,670,000 shares $6.53 million -52.6%3.6%2 $3.91 6/15/20213,520,000 shares $15.52 million +0.6%6.5%4.4 $4.41 5/28/20213,500,000 shares $14.53 million -6.2%6.5%3.7 $4.15 5/14/20213,730,000 shares $12.31 million -11.8%N/A1.2 $3.30How to trade Executive Order 14154 (Ad)Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orders. Among this blizzard of directives – ranging from slapping 25% tariffs on steel to banning the forced use of paper straws… Everyone seems to have missed the most important detail of all. Get the true, untold story of what’s hidden inside Executive Order 14154, here. 4/30/20214,230,000 shares $16.37 million -10.2%N/A1.2 $3.87 4/15/20214,710,000 shares $18.13 million -18.5%N/A1.2 $3.85 3/31/20215,780,000 shares $22.25 million -29.1%N/A1.4 $3.85 3/15/20218,150,000 shares $33.42 million +153.1%N/A2 $4.10 2/26/20213,220,000 shares $9.50 million +17.1%8.4%0.7 $2.95 2/12/20212,750,000 shares $9.19 million -6.5%7.2%1.2 $3.34 1/29/20212,940,000 shares $7.67 million -8.4%8.2%1.4 $2.61 1/15/20213,210,000 shares $8.25 million -7.2%8.9%1.8 $2.57 12/31/20203,460,000 shares $8.23 million -10.1%9.6%2.3 $2.38 12/15/20203,850,000 shares $10.16 million +11.3%10.7%2.8 $2.64 11/30/20203,460,000 shares $21.76 million +13.4%9.6%3.1 $6.29 11/15/20203,050,000 shares $18.42 million +15.1%8.5%3.2 $6.04 10/30/20202,650,000 shares $13.91 million +0.8%6.9%2.8 $5.25 10/15/20202,630,000 shares $14.96 million -38.0%6.9%2.7 $5.69 9/30/20204,240,000 shares $24.34 million +20.8%11.1%4.2 $5.74 9/15/20203,510,000 shares $22.50 million -22.5%9.9%2.9 $6.41 8/31/20204,530,000 shares $26.00 million +51.0%12.7%2.8 $5.74 8/14/20203,000,000 shares $22.50 million +2.7%9.7%1.8 $7.50 7/31/20202,920,000 shares $18.83 million +15.4%9.5%2 $6.45 7/15/20202,530,000 shares $18.60 million -30.1%8.6%1.7 $7.35 6/30/20203,620,000 shares $26.68 million +170.2%12.3%2.5 $7.37 6/15/20201,340,000 shares $7.60 million +58.6%4.6%1.1 $5.67 5/29/2020844,800 shares $4.52 million -37.4%2.9%1 $5.35 5/15/20201,350,000 shares $5.55 million -18.2%4.6%1.7 $4.11 4/30/20201,650,000 shares $6.01 million +20.4%5.7%2.7 $3.64 4/15/20201,370,000 shares $4.64 million +8.7%4.7%2.5 $3.39 3/31/20201,260,000 shares $4.30 million -43.2%4.4%2.2 $3.41 3/13/20202,216,300 shares $6.29 million +21.8%9.8%3.5 $2.84 2/28/20201,820,000 shares $4.40 million +94.6%8.0%2.7 $2.42 OVID Short Interest - Frequently Asked Questions What is Ovid Therapeutics' current short interest? Short interest is the volume of Ovid Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 883,700 shares of OVID short. 1.59% of Ovid Therapeutics' shares are currently sold short. Learn More on Ovid Therapeutics' current short interest. What is a good short interest ratio for Ovid Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OVID shares currently have a short interest ratio of 2.0. Learn More on Ovid Therapeutics's short interest ratio. Which institutional investors are shorting Ovid Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ovid Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Ovid Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.59% of Ovid Therapeutics' floating shares are currently sold short. Is Ovid Therapeutics' short interest increasing or decreasing? Ovid Therapeutics saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 883,700 shares, an increase of 25.3% from the previous total of 705,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ovid Therapeutics' float size? Ovid Therapeutics currently has issued a total of 71,010,000 shares. Some of Ovid Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ovid Therapeutics currently has a public float of 55,620,000 shares. How does Ovid Therapeutics' short interest compare to its competitors? 1.59% of Ovid Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ovid Therapeutics: Lyell Immunopharma, Inc. (7.64%), Zentalis Pharmaceuticals, Inc. (6.81%), CARGO Therapeutics, Inc. (18.87%), Vaxart, Inc. (4.88%), Acrivon Therapeutics, Inc. (5.01%), Cidara Therapeutics, Inc. (2.97%), Alector, Inc. (7.25%), Aclaris Therapeutics, Inc. (5.49%), Greenwich LifeSciences, Inc. (10.90%), Innate Pharma S.A. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Ovid Therapeutics stock? Short selling OVID is an investing strategy that aims to generate trading profit from Ovid Therapeutics as its price is falling. OVID shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ovid Therapeutics? A short squeeze for Ovid Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OVID, which in turn drives the price of the stock up even further. How often is Ovid Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OVID, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies LYEL Short Squeeze ZNTL Short Squeeze CRGX Short Squeeze VXRT Short Squeeze ACRV Short Squeeze CDTX Short Squeeze ALEC Short Squeeze ACRS Short Squeeze GLSI Short Squeeze IPHA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OVID) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovid Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
